Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India
Reviewers:
(1) oğuzhan YÜKSEL, Kutahya Dumlupinar University, Turkey.
(2) M. de los ANGELES CALVO TORRAS, Universitat Autònoma de Barcelona (Universidad Autónoma de Barcelona (UAB)), Spain.
(3) Anup De, Visva-Bharati University, India.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.5/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (oğuzhan YÜKSEL, Turkey) | File 1 | NA
Stage 2 | Peer review report_2 (M. de los ANGELES CALVO TORRAS, Spain) | File 1 | File 2
Stage 2 | Peer review report_3 (Anup De, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA